Open an Account
search icon
1
NOTIFICATIONS
Best Algo trading app in India
Bigul

Krishna Institute of Medical Sciences Ltd - 543308 - Board to consider Dividend

 With reference to the earlier letter dated May 12, 2022, with regard to consider and approve the standalone and consolidated audited financial results for the quarter and year ended March 31, 2022, Krishna Institute of Medical Sciences Ltd has now informed BSE that the Boatd of Directors may also recommend the dividend (if any) for FY 2021-22, in its meeting to be held on May 19, 2022.In furtherance to the intimation dated March 30, 2022, the trading window will open 48 hours after the announcement / declaration of the Financial Results of the company for the quarter and year ended March 31, 2022.
17-05-2022
Bigul

Krishna Institute of Medical Sciences Ltd - 543308 - Update on board meeting

 Krishna Institute Of Medical Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2022 ,inter alia, to consider and approve Update on board meeting
16-05-2022
Bigul

Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 press release on the proposed acquisition of equity shares of KIMS Manavata Hospitals Private Limited
14-05-2022
Bigul

Krishna Institute of Medical Sciences Ltd - 543308 - Newspaper Advertisement

 Publication of the Postal Ballot Notice in News paper.
13-05-2022
Bigul

Krishna Institute of Medical Sciences Ltd - 543308 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

 Notice of postal Ballot
12-05-2022
Bigul

Krishna Institute of Medical Sciences Ltd - 543308 - Board Meeting Intimation for A Meeting Of The Board Of Directors Of The Company Will Be Held On Thursday, 19Th May, 2022 Inter-Alia To Consider And Approve, The Standalone And Consolidated Audited Financial Results For The Quarter And Year Ended 31St March, 2022.

 Krishna Institute Of Medical Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2022 ,inter alia, to consider and approve the standalone and consolidated audited financial results for the quarter and year ended 31st March, 2022
12-05-2022
Bigul

Krishna Institute of Medical Sciences Ltd - 543308 - Certificate Under Regulation 40(9) Of SEBI (LODR) Regulations 2015

 Certificate under Regulation 40(9) of SEBI (LODR) Regulations 2015
29-04-2022
Bigul

Krishna Institute of Medical Sciences Ltd - 543308 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate

 Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayKrishna Institute of Medical Sciences Ltd 2CINU55101TG1973PLC040558 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 185114285.00 4Highest Credit Rating during the previous FY AA- 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)CRISIL LTD. 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. YES Name of the Company Secretary: Umashankar Mantha Designation: GM Legal and Company Secretary EmailId: cs@kimshospitals.com Name of the Chief Financial Officer: Vikas Maheshwari Designation: CFO EmailId: vikas@kimshospitals.com Date: 23/04/2022 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
23-04-2022
Bigul

Krishna Institute of Medical Sciences Ltd - 543308 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 We hereby enclose the Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31 March, 2022 as received from Link Intime India Private Limited, Registrar and Share Transfer Agent of our Company
14-04-2022
Bigul

Krishna Institute of Medical Sciences Ltd - 543308 - Compliance Certificate - Regulation 7 (3) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.

 we hereby confirm that all activities in relation to both physical and electronic share transfer facility during the period June 28, 2021 i.e. date of listing to March 31, 2022 (both days inclusive) are maintained by the Company's Registrar and Share Transfer Agent, viz., Link Intime India Pvt. Ltd a Category-I, Registrar & Share Transfer Agent (RTA), registered with the Securities and Exchange Board of India (SEBI) vide Registration Number: INR000004058..
09-04-2022
Next Page
Close

Let's Open Free Demat Account